Most genetic engineering applications reported thus far rely on the type II-A CRISPR-Cas9 nuclease from Streptococcus pyogenes (SpyCas9), limiting the genome-targeting scope. In this study, we demonstrate that a small, naturally accurate, and thermostable type II-C Cas9 ortholog from Geobacillus thermodenitrificans (ThermoCas9) with alternative target site preference is active in human cells, and it can be used as an efficient genome editing tool, especially for gene disruption. In addition, we develop a ThermoCas9-mediated base editor, called ThermoBE4, for programmable nicking and subsequent C-to-T conversions in human genomes. ThermoBE4 exhibits a three times larger window of activity compared with the corresponding SpyCas9 base editor (BE4), which may be an advantage for gene mutagenesis applications. Hence, ThermoCas9 provides an alternative platform that expands the targeting scope of both genome and base editing in human cells.
Get full access to this article
View all access options for this article.
References
1.
BarrangouR, FremauxC, DeveauH, et al.CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007; 315:1709–1712; doi: 10.1126/science.1138140
2.
BrounsSJ, JoreMM, LundgrenM, et al.Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 2008; 321:960–964; doi: 10.1126/science.1159689
3.
MohanrajuP, SahaC, van BaarlenP, et al.Alternative functions of CRISPR-Cas systems in the evolutionary arms race. Nat Rev Microbiol, 2022; 20:351–364; doi: 10.1038/s41579-021-00663-z
4.
DoudnaJA, CharpentierE. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014; 346:1258096; doi: 10.1126/science.1258096
5.
HsuPD, LanderES, ZhangF. Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014; 157:1262–1278; doi: 10.1016/j.cell.2014.05.010
6.
WuWY, LebbinkJH, KanaarR, et al.Genome editing by natural and engineered CRISPR-associated nucleases. Nat Chem Biol, 2018; 14:642–651; doi: 10.1038/s41589-018-0080-x
7.
NidhiS, AnandU, OleksakP, et al.Novel CRISPR-Cas systems: An updated review of the current achievements, applications, and future research perspectives. Int J Mol Sci, 2021; 22:3327; doi: 10.3390/ijms22073327
8.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821; doi: 10.1126/science.1225829
9.
DeveauH, BarrangouR, GarneauJE, et al.Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol, 2008; 190:1390–1400; doi: 10.1128/JB.01412-07
10.
MojicaFJ, Díez-VillaseñorC, García-MartínezJ, et al.Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology, 2009; 155:733–740; doi: 10.1099/mic.0.023960-0
11.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823; doi: 10.1126/science.1231143
12.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826; doi: 10.1126/science.1232033
13.
RouetP, SmihF, JasinM. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci, 1994; 91:6064–6068; doi: 10.1073/pnas.91.13.6064
14.
ChapmanJR, TaylorMR, BoultonSJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell, 2012; 47:497–510; doi: 10.1016/j.molcel.2012.07.029
KomorAC, KimYB, PackerMS, et al.Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016; 533:420–424; doi: 10.1038/nature17946
17.
NishidaK, ArazoeT, YachieN, et al.Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science, 2016; 353:aaf8729; doi: 10.1126/science.aaf8729
18.
GaudelliNM, KomorAC, ReesHA, et al.Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature, 2017; 551:464–471; doi: 10.1038/s41586-018-0070-x
19.
KomorAC, ZhaoKT, PackerMS, et al.Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C: G-to-T: A base editors with higher efficiency and product purity. Sci Adv, 2017; 3:eaao4774; doi: 10.1126/sciadv.aao4774
20.
ReesHA, LiuDR. Base editing: Precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet, 2018; 19:770–788; doi: 10.1038/s41576-018-0059-1
21.
MakarovaKS, WolfYI, IranzoJ, et al.Evolutionary classification of CRISPR-Cas systems: A burst of class 2 and derived variants. Nat Rev Microbiol, 2020; 18:67–83; doi: 10.1038/s41579-019-0299-x
22.
ShmakovS, SmargonA, ScottD, et al.Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol, 2017; 15:169–182; doi: 10.1038/nrmicro.2016.184
23.
ChylinskiK, MakarovaKS, CharpentierE, et al.Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res, 2014; 42:6091–6105; doi: 10.1093/nar/gku241
24.
FonfaraI, Le RhunA, ChylinskiK, et al.Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res, 2014; 42:2577–2590; doi: 10.1093/nar/gkt1074
25.
GasiunasG, YoungJK, KarvelisT, et al.A catalogue of biochemically diverse CRISPR-Cas9 orthologs. Nat Commun, 2020; 11:1–10; doi: 10.1038/s41467-020-19344-1
26.
KimYB, KomorAC, LevyJM, et al.Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol, 2017; 35:371–376; doi: 10.1038/nbt.3803
27.
LiuZ, ChenS, JiaY, et al.Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide. Sci China Life Sci, 2021; 64:1355–1367; doi: 10.1007/s11427-020-1775-2
28.
HouZ, ZhangY, PropsonNE, et al.Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci, 2013; 110:15644–15649; doi: 10.1073/pnas.1313587110
29.
IbraheimR, SongCQ, MirA, et al.All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. Genome Biol, 2018; 19:1–11; doi: 10.1186/s13059-018-1515-0
30.
LeeCM, CradickTJ, BaoG. The Neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells. Mol Ther, 2016; 24:645–654; doi: 10.1038/mt.2016.8
31.
FriedlandAE, BaralR, SinghalP, et al.Characterization of Staphylococcus aureus Cas9: A smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biology, 2015; 16:1–10; doi: 10.1186/s13059-015-0817-8
32.
RanFACL, CongL, YanWX, et al.In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015; 520:186–191; doi: 10.1038/nature14299
33.
KimE, KooT, ParkSW, et al.In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat Commun, 2017; 8:1–12. DOI: 10.1038/ncomms14500.
34.
AcharyaS, MishraA, PaulD, et al.Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing. Proc Natl Acad Sci, 2019; 116:20959–20968; doi: 10.1073/pnas.1818461116
35.
AgudeloD, CarterS, VelimirovicM, et al.Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9. Genome Res, 2020; 30:107–117; doi: 10.1101/gr.255414.119
36.
MüllerM, LeeCM, GasiunasG, et al.Streptococcus thermophilus CRISPR-Cas9 systems enable specific editing of the human genome. Mol Ther, 2016; 24:636–644; doi: 10.1038/mt.2015.218
37.
ChatterjeeP, JakimoN, JacobsonJM. Minimal PAM specificity of a highly similar SpCas9 ortholog. Sci Adv, 2018; 4:eaau0766; doi: 10.1126/sciadv.aau0766
38.
HuZ, WangS, ZhangC, et al.A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope. PLoS Biol, 2020; 18:e3000686; doi: 0.1371/journal.pbio.3000686
39.
LiX, QianX, WangB, et al.Programmable base editing of mutated TERT promoter inhibits brain tumour growth. Nat Cell Biol, 2020; 22:282–288; doi: 10.1038/s41556-020-0471-6
40.
XuK, RenC, LiuZ, et al.Efficient genome engineering in eukaryotes using Cas9 from Streptococcus thermophilus. Cell Mol Life Sci, 2015; 72:383–399; doi: 10.1007/s00018-014-1679-z
41.
FedorovaI, VasilevaA, SelkovaP, et al.PpCas9 from Pasteurella pneumotropica—A compact Type II-C Cas9 ortholog active in human cells. Nucleic Acids Res, 2020; 48:12297–12309; doi: 10.1093/nar/gkaa998
42.
HarringtonLB, Paez-EspinoD, StaahlBT, et al.A thermostable Cas9 with increased lifetime in human plasma. Nat Commun, 2017; 8:1–8; doi: 10.1038/s41467-017-01408-4
43.
BolukbasiMF, LiuP, LukK, et al.Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing. Nat Commun, 2018; 9:1–12; doi: 10.1038/s41467-018-07310-x
44.
EsveltKM, MaliP, BraffJL, et al.Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods, 2013; 10:1116–1121; doi: 10.1038/nmeth.2681
45.
TakasugiPR, WangS, TruongKT, et al.Orthogonal CRISPR-Cas tools for genome editing, inhibition, and CRISPR recording in zebrafish embryos. Genetics, 2022; 220:iyab196; doi: 10.1093/genetics/iyab196
46.
TrasanidouD, GerósAS, MohanrajuP, et al.Keeping crispr in check: Diverse mechanisms of phage-encoded anti-crisprs. FEMS Microbiol Lett, 2019; 366:fnz098; doi: 10.1093/femsle/fnz098
47.
MougiakosI, MohanrajuP, BosmaEF, et al.Characterizing a thermostable Cas9 for bacterial genome editing and silencing. Nat Commun, 2017; 8:1–11; doi: 10.1038/s41467-017-01591-4
48.
GreenR, RogersEJ. Transformation of chemically competent E. coli. Methods Enzymol, 2013; 529:329–336; doi: 10.1016/B978-0-12-418687-3.00028-8
49.
KluesnerMG, NedveckDA, LahrWS, et al.EditR: A method to quantify base editing from Sanger sequencing. CRISPR J, 2018; 1:239–250; doi: 10.1089/crispr.2018.0014
50.
AnantS, MacGinnitieAJ, DavidsonNO. Apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem, 1995; 270:14762–14767; doi: 10.1074/jbc.270.24.14762
51.
ZhigangW, SmithDG, MosbaughDW. Overproduction and characterization of the uracil-DNA glycosylase inhibitor of bacteriophage PBS2. Gene, 1991; 99:31–37; doi: 10.1016/0378-1119(91)90030-f
52.
ChenF, DingX, FengY, et al.Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting. Nat Commun, 2017; 8:1–12; doi: 10.1038/ncomms14958
53.
TsuiTKM, HandTH, DuboyEC, et al.The impact of DNA topology and guide length on target selection by a cytosine-specific Cas9. ACS Synth Biol, 2017; 6:1103–1113; doi: 10.1021/acssynbio.7b00050
54.
GarneauJE, DupuisMÈ, VillionM, et al.The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 2010; 468:67–71; doi: 10.1038/nature09523
55.
GasiunasG, BarrangouR, HorvathP, et al.Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci, 2012; 109:E2579–E2586; doi: 10.1073/pnas.1208507109
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
